The Wisconsin epdmp:

Similar documents
SENATE, No STATE OF NEW JERSEY. 216th LEGISLATURE INTRODUCED APRIL 28, 2014

District of Columbia Prescription Drug Monitoring Program

Prescription Monitoring Program State Profiles - California

Prescription Monitoring Program State Profiles - Illinois

Prescription Monitoring Program State Profiles - Texas

NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT

Delegator Dashboard User Guide

States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP

States that Allow Prescribers and/or Dispensers to Appoint a Delegate to Access the PMP

Legal Issues in Managing Opioid Abuse. Gwen Dayton, JD

10/4/12. Controlled Substances Dispensing Issues and Solutions. Objectives. Financial Disclosure

Interim Commissioner Lauren A. Smith and Members of the Public Health Council

Prescription Drug Monitoring Program (PDMP)

Types of Authorized Recipients Probation/Parole Officers or the Department of Corrections

PRESCRIPTION MONITORING PROGRAM STATE PROFILES TENNESSEE

PATIENT RIGHTS TO ACCESS PERSONAL MEDICAL RECORDS California Health & Safety Code Section

Payment: We are permitted to use and disclose your health information to receive payment for our services. For example, we may:

RULES and REGULATIONS: PRESCRIBING CONTROLLED SUBSTANCES IN MS. Mississippi State Board of Medical Licensure June 24, 2016 Thomas Washington, CMBI

Pharmacy Law Update for Pharmacists & Technicians October 1, 2017 Greg Baran, B.S., Pharm., M.A.

Prescription Monitoring Program State Profiles - Pennsylvania

Prescription Monitoring Programs - Legislative Trends and Model Law Revision

Alabama. Prescribing and Dispensing Profile. Research current through November 2015.

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: March 2016

OKLAHOMA ADMINISTRATIVE CODE TITLE 435. STATE BOARD OF MEDICAL LICENSURE AND SUPERVISION CHAPTER 15. PHYSICIAN ASSISTANTS INDEX

STATE OF TEXAS TEXAS STATE BOARD OF PHARMACY

ALABAMA~STATUTE. Code of Alabama et seq. DATE Enacted Alabama Board of Medical Examiners

MARYLAND BOARD OF PHYSICIANS P.O. Box 2571 Baltimore, Maryland

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES & CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS

Opp Health and Rehabilitation, LLC 115 Paulk Avenue P.O. Box 730 Opp, AL Phone Number: (334)

OREGON HEALTH AUTHORITY, DIVISION OF MEDICAL ASSISTANCE PROGRAMS

Frequently Asked Questions

Summer Webinar Series. The Prescription Drug Monitoring Program (PDMP) Mandate and Where you Fit In June 21, 2018

South Carolina Reporting & Identification Prescription Tracking System (SCRIPTS)

Maryland. Prescribing and Dispensing Profile. Research current through November 2015.

Bold blue=new language Red strikethrough=deleted language Regular text=existing language Bold Green = new changes following public hearing

New Mexico. Contact Information. State Registrant Totals and Population. PDMP name: NM PMP

RULE DELEGATION AND SUPERVISION OF MEDICAL SERVICES TO UNLICENSED HEALTH CARE PROVIDERS PURSUANT TO SECTION (3)(l), C.R.S.

Health and Human Services Task Force Spring Task Force Summit Pittsburgh, PA May 6, 2016

(7) Indicate the appropriate and explicit directions for use. (9) Not authorize any refills for schedule II controlled substances.

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE

ASSEMBLY, No STATE OF NEW JERSEY. 214th LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2010 SESSION

Table of Contents. Introduction: Basis, purpose and statutory provision

Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

ASSEMBLY BILL No. 214

South Carolina Compliance Update

Reporting Requirements and Exemptions to Reporting

Prescription Drug Monitoring Program (PDMP)

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2015 HOUSE DRH20205-MG-112 (03/24) Short Title: Enact Death With Dignity Act. (Public)

North Carolina. Contact Information. State Registrant Totals and Population. PDMP region: PDMP name: Agency responsible:

Report of the Task Force on Prescription Monitoring Program Standards

Understanding the Pharmacy and Drug Act amendments and mail order pharmacy licensing

Page 1 CHAPTER 31 SCREENING OUTREACH PROGRAM. 10: Screening process and procedures

Georgia DPH. Prescription Title Drug Heading Monitoring Program Program. Sheila Pierce April 2018

Chapter 1: Overview of Texas Pharmacy Law 1 Contact Hour (Mandatory)

The District of Columbia Death with Dignity Act (Patient Request for Medical Aid-in-Dying)

HEALTH CARE PROVIDERS IMMUNITY FROM LIABILITY ACT

THE CHILDREN S INSTITUTE OF PITTSBURGH NOTICE OF PRIVACY PRACTICES

Prescription Monitoring Program State Profiles - Michigan

Release of Medical Records in Ohio OHIMA. Ohio Revised Code (ORC) HIPAA

AN ACT authorizing the provision of health care services through telemedicine and telehealth, and supplementing various parts of the statutory law.

AN ACT. Be it enacted by the General Assembly of the State of Ohio:

247 CMR: BOARD OF REGISTRATION IN PHARMACY

Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

Applicable State Licensing Requirements for Combined Federal and Comprehensive HHA Survey

A Bill Regular Session, 2015 HOUSE BILL 1162

Prescription Monitoring Program State Profiles - Kentucky

Advanced Practice Nurses Authority to Diagnose and Prescribe. Excellence Through Coordinated Patient Care. Copyright protected. information.

DC Board of Pharmacy and Pharmaceutical Control Update

Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

POSITION STATEMENT. - desires to protect the public from students who are chemically impaired.

Senate Bill No. 294 Senators Cegavske and Leslie

NOTICE OF PRIVACY PRACTICES

Thank you for coming to our San Antonio Workshop THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

SUBCHAPTER 32M - APPROVAL OF NURSE PRACTITIONERS

HIPAA Notice of Privacy Practices

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-19 PAIN MANAGEMENT SEVICES TABLE OF CONTENTS

Prescription Drug Monitoring Program (PDMP) LOUISIANA. Information contained in this presentation is accurate as of September 2017

STATE OF RHODE ISLAND

Physician Assistant Jurisprudence Examination

Florida s New Law on Controlled Substance Prescribing

Be it enacted by the General Assembly of the Commonwealth of Kentucky: Section 1. KRS is amended to read as follows:

Alaska. Contact Information. State Registrant Totals and Population. PDMP name: AKPDMP

NOTICE OF PRIVACY PRACTICES

THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE BILL AN ACT

CHAPTER 4 ADVANCED PRACTITIONERS OF NURSING. These rules and regulations are adopted to implement the board's authority to:

BON RULE CHANGES. Rule 213. Practice & Procedure Corrective Action Deferred Action K-STAR (New Rule)

Chapter II OVERVIEW OF THE MEDICAL BOARD OF CALIFORNIA

Regulatory Issues Facing Student Health Centers Presented by: Richard T. Yarmel and Edward H. Townsend

FAQ about the Death With Dignity Act

Section (1), Stats. Statutory authority: Sections (5) (b), (2) (a), and (1), Stats. Explanation of agency authority:

IC Chapter 19. Regulation of Pharmacy Technicians

Your Medical Record Rights in Wisconsin

Nevada. Contact Information. State Registrant Totals and Population

Senate Bill No. 190 Senator Denis

Referred to Committee on Health and Human Services. SUMMARY Provides for schools to obtain and administer autoinjectable epinephrine.

2514 Stenson Dr Cedar Park TX Fax

Mental Health. Notice of Privacy Practices

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-8 ADVANCED PRACTICE NURSES: COLLABORATIVE PRACTICE TABLE OF CONTENTS

FAMILY PHARMACEUTICAL SERVICES NOTICE OF PRIVACY PRACTICES effective 9/23/2013

FAQ about Physician-Assisted Death

Transcription:

The Wisconsin epdmp: Frequently Asked Questions Pursuant to 2015 Wisconsin Act 266, effective April 1, 2017, Wisconsin-licensed physicians and other prescribers must review a patient s records from Wisconsin s Enhanced Prescription Drug Monitoring Program (epdmp) before issuing a prescription order for a monitored prescription drug. The requirement, part of the Wisconsin legislature s Heroin, Opioid Prevention and Education (HOPE) Agenda, applies to each prescription order for a controlled substance unless one of the following exceptions applies: 1) The patient is receiving hospice care. 2) The prescription is for a three-day or less supply with no refills. 3) The drug is lawfully administered to the patient. 4) Due to an emergency, it is not possible to review the epdmp before issuing the prescription. 5) The practitioner is unable to review the epdmp data because either the epdmp or the means to access it are not operational. The following FAQs discuss the details and some common questions regarding this requirement. They are for informational purposes only and are not intended to constitute legal advice. Please consult your legal counsel for answers to specific questions, including whether a given course of action complies with this requirement. Nothing in these FAQs is intended to take the place of legal advice provided by your own legal counsel as well as your internal policies, procedures and directions. Additional information regarding the epdmp, including training materials and contact information, is available on the epdmp website: http://dsps.wi.gov/pdmp/ Who must comply with this requirement? The requirement applies to all practitioners any person licensed to prescribe and administer drugs in Wisconsin or licensed in another state and authorized to do so in Wisconsin. This includes physicians, physician assistants (PA), advanced practice nurse practitioners (APNP), optometrists, dentists and podiatrists. What drugs or substances are subject to this requirement? A practitioner must review a patient s records from the epdmp before issuing a prescription order for a monitored prescription drug unless one of five exceptions apply. A monitored prescription drug is any Schedule II, III, IV and V controlled substance as well as any other drug identified by the Wisconsin Controlled Substances Board (CSB) as having a substantial potential for abuse. As of April 3, 2017, there were no monitored prescription drugs other than Schedule II V controlled substances. The requirement to review patient records from the epdmp before issuing a prescription order applies to all controlled substances, not just opioids or Schedule II drugs. While Wisconsin s list of controlled substances closely parallels its federal counterpart, they are not identical. For a complete list of controlled substances subject to the requirement see Subchapter II of the Wisconsin Uniform Controlled Substances Act (Chapter 961). Prescribers should always know whether a drug is a controlled substance under state or federal law before prescribing it, as well as any requirements or limitations that may apply to that drug. When does the requirement take effect? Starting April 1, 2017, practitioners must review a patient s records from the epdmp before issuing a prescription order for a controlled substance. The requirement is scheduled to sunset (end) three years after taking effect.

Are there any exceptions to this requirement? Yes. A practitioner is not required to review a patient s records from the epdmp before issuing a prescription order for a controlled substance if one or more of the following exceptions apply: The patient is receiving hospice care. The prescription order is for an amount intended to be a three-day supply or less, The drug is administered directly to the patient. Due to an emergency, it is not possible to review the patient s epdmp records before issuing the prescription. The epdmp is not operational or a technological failure prevents the practitioner from accessing the epdmp, provided the practitioner reports the failure to the Controlled Substances Board. In addition, a practitioner is not required, but is permitted, to review a patient s records from the epdmp before prescribing a non-controlled substance. Does the requirement apply to repeat orders for the same drug and/or dosage? Yes. Unless one of the above exceptions applies, a practitioner is required to review a patient s records from the epdmp before each issuance of a prescription order for a controlled substance. This includes re-orders or renewal prescriptions for ongoing therapy, including for the same dosage. Should review of epdmp records be documented in the patient s medical record? The Society recommends that each review of epdmp records for a patient be documented in the patient s medical record. The manner and contents of such documentation should be determined by practitioners in consultation with legal counsel. What are the penalties for failure to review a patient s epdmp records where required by law? Though the Controlled Substances Board has indicated that its priority is to promote educate and train practitioners about the benefits and requirements of the epdmp, it also has discretion to refer matters of noncompliance to a practitioner s licensing board for investigation. Failure by a physician to review a patient s records from the epdmp before issuing a prescription order where required by law is a form of unprofessional conduct that may result in discipline by the Medical Examining Board. Can I access the epdmp if I am not prescribing a controlled substance? Yes. Practitioners may access an individual s records from the epdmp if the individual is a current patient or the practitioner is consulting with another practitioner regarding that patient and access of the individual s records is for purposes of the patient s care or treatment. How close in time must a required review be to the prescription order? The amount of time between when a patient s records from the epdmp are reviewed and when a prescription for a controlled substance for that patient is issued must be reasonable under the circumstances i.e. would a reasonable physician under the same or similar circumstances consider the review sufficiently close in time to the prescription order to serve its intended purpose. The Society recommends practitioners review a patient s epdmp records contemporaneous with the issuance of a prescription order for a controlled substance where possible. Information regarding each dispensing of a controlled substance must be submitted to the epdmp by pharmacies and dispensing physicians by the end of the next business day after the substance is dispensed. As such, limiting the amount of time between the review of a patient s epdmp records and the issuance of a prescription order to one business day should generally provide practitioners with current information regarding a patient s prescription history. Practitioners should consult their legal counsel and/or compliance team for specific guidance as more or less time may be permissible or advised in certain settings or circumstances. 2 Wisconsin Medical Society epdmp FAQs

Can practitioners utilize staff to assist in performing the required review? Yes; although there remains a need for greater clarity regarding the extent to which staff may be utilized. Practitioners may authorize licensed and unlicensed individuals to act on their behalf or at their direction ( agents ), including authorizing such individuals to access the epdmp for them ( practitioner delegates ). However, the responsibility to review a patient s records from the epdmp before issuing a prescription order for a controlled substance rests with the practitioner. The responsibility cannot be assumed by the practitioner s employer or facility and cannot be delegated completely to agents or staff of the practitioner. The Society recommends practitioners consult their legal counsel and/or compliance team for specific guidance regarding how and to what extent staff may be utilized to comply with this requirement. The Society recommends that practitioners directly view patients epdmp records before issuing each prescription order for a controlled substance whenever possible. Practitioners may use agents to assist in this task by, for example, retrieving the relevant patient records from the epdmp. Practitioners also have the general authority to delegate medical acts to certain licensed and unlicensed individuals depending on the delegate s scope of practice, license, education, knowledge, experience and other factors. To what extent this may allow a delegate to provide assistance to practitioners in complying with this requirement beyond accessing the epdmp and providing the patient s epdmp records to the practitioner for review remains an open question. The Society is working with the state legislature and the Department of Safety and Professional Services to seek greater clarity and necessary flexibility for practitioners. However, practitioners remain ultimately responsible for reviewing a patient s records from the epdmp before issuing a prescription order for a controlled substance. Is epdmp data confidential? epdmp data contains patient health information subject to HIPAA and Wisconsin s patient health care records confidentiality law. Therefore, epdmp information should be treated similarly to other forms of patient health care records received from another provider or source. This includes protecting its confidentiality, limiting access and taking required measures to prevent the disclosure of such records unless authorized by the patient or for which patient authorization is not required (such as disclosure for purposes of health care treatment, payment and operations). Can epdmp data be shared with patients? Practitioners may show a patient his or her own epdmp records as part of treating or rendering assistance to the patient. Practitioners should be prepared to discuss the epdmp with patients, including its purpose and how the information is used. The Society recommends practitioners consult their risk manager and/or legal counsel to determine under what circumstances to disclose epdmp information to patients and how to do so in the most effective manner. Patients also can request a copy of their epdmp records directly from the Department of Safety and Professional Services in person or by mail. If epdmp records are incorporated into a patient s medical record, those records should be included in a production in response to a lawful request for the patient s records. What is the penalty for improper access or disclosure of epdmp records? A person who improperly accesses or discloses epdmp records in violation of the law, including HIPAA and Wisconsin s health care records confidentiality law, may be referred to the appropriate licensing or regulatory board for discipline, or the appropriate law enforcement agency for investigation and possible prosecution. Who has access to the epdmp and its data? The following individuals are permitted access to epdmp data for purposes of directly treating or rendering assistance to a patient or participating in a consult for a provider directly treating a patient: Practitioners (physicians, PAs, APNPs, dentists, optometrists, podiatrists) Pharmacists The agent of a practitioner or pharmacist Registered nurses 3 Wisconsin Medical Society epdmp FAQs

Substance abuse counselors Individuals licensed to treat alcohol or substance dependency or abuse as a specialty Will the epdmp record each time a patient s records are accessed? Yes. The epdmp contains audit trails that log each access of the epdmp, by whom and for what patient. This information will be available to practitioners (including audit trails of any delegate), certain other individuals, and to regulatory boards and law enforcement under limited circumstances. (See below for more information.) Practitioners should periodically review their audit trails to ensure they accurately reflect the practitioner s activity. Can a Chief Medical Officer, Quality Improvement Officer or other individuals who supervise or work with practitioners access prescribing information about a practitioner from the epdmp? A person who medically coordinates, directs, supervises or establishes standard operating procedures for the above individuals may access epdmp records if the person is evaluating the job performance of the above individuals or is performing quality assessment and improvement activities, including outcomes evaluations or development of clinical guidelines. Such access is limited to information about the prescribing of the above individuals and will not contain patient-identifying information. Can the Wisconsin Medical Examining Board or other regulatory and licensing boards, law enforcement or criminal prosecutors review epdmp data and who accessed the epdmp? Certain state boards and agencies, in Wisconsin or other states with which Wisconsin has a collaborative relationship, relevant law enforcement agencies and relevant prosecutorial units may have access to epdmp under the following limited circumstances: The agency or unit makes a written request for a record reasonably related to a specific investigation or prosecution of violation of a state or federal law that involves a monitored prescription drug. The agency or unit makes a written request for the record and is monitoring the patient as part of a drug court. Circumstances indicate suspicious or crucially dangerous conduct or practices of a pharmacy, pharmacist, practitioner or patient. The Controlled Substances Board also has authority to review audit trails, dispensing data and other epdmp data to determine whether circumstances indicate suspicious or critically dangerous conduct or practices of a practitioner and may refer individuals associated with such conduct or practices to the appropriate licensing board or appropriate law enforcement agency for investigation and possible prosecution. Does the requirement apply to prescriptions to residents of nursing homes or other inpatient or residential facilities? There is no specific exception for inpatient settings or certain types of facilities. However, a practitioner is not required to review a patient s records from the epdmp before issuing a prescription for a controlled substance if that substance is lawfully administered to the patient. Administer means the direct application of a monitored prescription drug, whether by injection, ingestion, or any other means, to the body of a patient by a practitioner, an agent of the practitioner, a pharmacist, or a patient at the direction of a practitioner. Whether a given process of providing a controlled substance to the resident of a nursing home or other facility constitutes administration depends on the individual facts and circumstances. The Society recommends practitioners review patients records from the epdmp before prescribing a controlled substance to patients in nursing homes and other facilities unless the practitioner has sufficient understanding of the procedures for medication distribution and administration in the facility to form a reasonable belief that the substance will be provided to the patient and taken in the presence of an agent of the facility qualified to administer that substance. Practitioners should consult legal counsel regarding whether review of the epdmp is necessary for a given set of circumstances. 4 Wisconsin Medical Society epdmp FAQs

Does this requirement apply to retired physicians or physicians who do not prescribe controlled substances? Yes. The requirement applies to a practitioner on each occasion he or she prescribes a controlled substance and none of the above five exceptions is met. There is no exception for retired physicians, physicians who do not routinely prescribe controlled substances or other specific classes of prescribers. The Society recommends that all physicians register with the epdmp regardless of their practice or status so they have the ability to access the epdmp if or when required or desired. Are Wisconsin-licensed practitioners required to check the epdmp for patients they see in another state? According to the Controlled Substances Board, if a practitioner licensed in Wisconsin does not practice in Wisconsin and therefore reasonably believes the patient has no records under the program, the practitioner would not be expected to review the patient s epdmp records before issuing a controlled substance prescription order. However, Wisconsin licensing and regulatory boards, such as the Wisconsin Medical Examining Board (MEB), have jurisdiction over licensees for acts outside the state of Wisconsin as well. Therefore, the Society recommends that a Wisconsin-licensed practitioner review patient records from the epdmp before issuing a controlled substance prescription order if any of the following apply: The patient is a resident of Wisconsin. The patient visit or treatment occurs in Wisconsin. There is other reason to believe that the Wisconsin epdmp may contain records for that patient (such as if the patient recently moved from Wisconsin). How do I report a technological failure that prevents me from checking the epdmp? Practitioners who are unable to access the epdmp because the digital platform for the program is not operational or due to another technological failure are only relieved of the requirement to review patient records for that occasion, and only if they report that failure to the Controlled Substances Board. To report a technological failure that prevents access to the epdmp, e-mail PDMP@wisconsin.gov with the subject line WI epdmp Tech Failure. The Society recommends against including any patient information in such notifications as doing so may constitute a breach of confidentiality. Any inability to review a patient s epdmp records otherwise required by law also should be documented in the patient s medical record. Where can I find more information about the epdmp, including how to register for and use the epdmp? Information regarding the epdmp, including training materials, tutorials, support documents and other information regarding registration, assigning delegates, using the epdmp, submitting data, and other topics, is available on the epdmp website: http://dsps.wi.gov/pdmp/ Contact Us PDMP technical support: PDMP administrative support: Phone: 608.250.4606 Phone: 608.266.2112 E-mail: PDMPSupport@egov.com E-mail: PDMP@wisconsin.gov For more information, contact John Rather, JD, (john.rather@wismed.org) or Mark Grapentine, JD, (mark.grapentine@wismed.org). Visit www.wisconsinmedicalsociety.org for updates. Last updated April 13, 2017.